Mackay Shields LLC Halozyme Therapeutics, Inc. Transaction History

Mackay Shields LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$38.84 - $51.31 $1.78 Million - $2.35 Million	-45,855 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$39.51 - $51.45 $1.25 Million - $1.63 Million	-31,723 Reduced 40.89%	45,855 $1.91 Million
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $301,977 - $510,353	-11,700 Reduced 13.11%	77,578 $3.31 Million
Q3 2020 Nov 04, 2020	SELL	$25.74 - $29.63 $633,204 - $728,898	-24,600 Reduced 21.6%	89,278 $2.35 Million
Q2 2020 Jul 31, 2020	BUY	$16.25 - $26.81 $56,875 - $93,835	3,500 Added 3.17%	113,878 $3.05 Million
Q1 2020 May 08, 2020	SELL	$13.9 - $21.83 $218,230 - $342,731	-15,700 Reduced 12.45%	110,378 $1.99 Million
Q4 2019 Feb 11, 2020	SELL	$14.93 - $19.53 $452,379 - $591,759	-30,300 Reduced 19.38%	126,078 $2.24 Million
Q3 2019 Nov 01, 2019	SELL	$15.2 - $17.69 $401,280 - $467,016	-26,400 Reduced 14.44%	156,378 $2.43 Million
Q2 2019 Aug 13, 2019	BUY	$14.75 - $17.26 $1.89 Million - $2.22 Million	128,423 Added 236.27%	182,778 $3.14 Million
Q1 2019 May 13, 2019	BUY	$13.94 - $17.58 $37,638 - $47,465	2,700 Added 5.23%	54,355 $875,000
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $176,062 - $246,461	-13,208 Reduced 20.36%	51,655 $756,000
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $353,616 - $390,292	21,200 Added 48.55%	64,863 $1.18 Million
Q2 2018 Aug 06, 2018	SELL	$16.87 - $20.3 $20,244 - $24,360	-1,200 Reduced 2.67%	43,663 $737,000
Q1 2018 May 03, 2018	BUY	$17.06 - $21.2 $765,362 - $951,095	44,863 New	44,863 $879,000

541

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.63B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.